A New York bill would ban chatbots from impersonating licensed professionals like doctors and lawyers and giving “substantive response, information, or advice”
A bill under consideration in New York would provide a private right of action, allowing people to file lawsuits against chatbot owners who violate the law.
Study: ChatGPT Health underestimated the severity of medical emergencies 51.6% of the time and overestimated the severity of nonurgent cases 64.8% of the time
Researchers tested different medical scenarios with the chatbot. In more than half of cases where doctors would send a patient to the ER …
NYC-based Garner Health, which uses data analytics to help 2.5M+ workers find physicians, raised a $118M Series D led by Kleiner Perkins at a $1.35B valuation
Nick Reber, Garner Health founder and CEO — Garner Health uses data to identify the country's best doctors based on quality and cost …
Interviews with 100+ therapists and psychiatrists on clients' AI chatbot usage show, while there are some upsides, conversations also deepened negative feelings
Dozens of doctors and therapists said chatbots had led their patients to psychosis, isolation and unhealthy habits.
OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025
OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025
A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion.
Source: OpenEvidence, which offers an AI chatbot for doctors, is raising $250M at a $12B valuation, up from $6B in Oct., and has $150M in annualized ad revenue
Stephanie Palazzolo / The Information : X: @steph_palazzolo and @arfurrock X: Stephanie Palazzolo / @steph_palazzolo : New! OpenEvidence, which offers a “ChatGPT for doctors,” is raising at a $12B va...
The US FDA qualifies the first AI drug development tool, AIM-NASH, to help doctors assess MASH, a fatty liver disease that can lead to liver failure or cancer
Sahil Pandey / Reuters :
A profile of AI contractor marketplace Mercor, which is valued at $10B and whose three 22-year-old founders are Thiel Fellows, each holding a roughly 22% stake
“Mercor, a recruiting startup that helps Silicon Valley's biggest AI labs … Bluesky: Dare Obasanjo / @carnage4life : The founders of Mercor are the world's youngest self made billionaires at 22 as the...
OpenEvidence, which makes an ad-supported AI chatbot for medical professionals, raised $200M at a $6B valuation, up from $3.5B after a $210M Series B in July
The three-year-old artificial intelligence start-up has drawn investor attention, and money, as its use among doctors, nurses and others skyrockets.